Become a digitalPLUS subscriber. 99 for 4 weeks.

Topics

Britain
AbbVie cools on $55 billion Shire deal after U.S. tax changes
AbbVie cools on $55 billion Shire deal after U.S. tax changes

LONDON (Reuters) - U.S. pharmaceutical company AbbVie said it was reconsidering its $55 billion takeover of Shire in the wake of U.S. government moves to curb deals designed to cut taxes, wiping as much as $13 billion off the London-listed firm's stock price. Chicago-based AbbVie said late on Tuesday it was responding to the U.S. proposals which aim to make it harder for American firms to shift their tax bases out of the country and into lower cost jurisdictions in Europe. AbbVie's move for Shire, a leader in drugs to treat attention deficit disorder and rare diseases, was announced in July amid a spate of similar takeover deals in the pharmaceutical sector. It proposed...

Loading